References
- Larsson M, Axelsson R, Foreman A. On the pharmacokinetics of perphenazine: A clinical study of perphenazine enanthate and decanoate. Curr Ther Res 1984; 36: 1071–88
- Knudsen P, Hansen L B, Larsen N-E. Perphenazine decanoate in sesame oil vs perphenazine enanthate in sesame oil: A comparative study of pharmacokinetic properties and some clinical implications. Acta Psych Scand 1985; 72(suppl 322)11–4
- Knudsen P, Bolvig Hansen L, Auken G, Waerens J, Höjdholt K, Larsen N-E. Perphenazine decanoate vs perphenazine enanthate: Efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients. Acta Psychiatr Scand 1985; 72(suppl 322)15–28
- Bolvig Hansen L, Larsen N-E. Plasma monitoring of perphenazine as an aid in the antipsychotic treatment. Nord Psykiatr Tidskr 1986; 40: 467–71
- Overall J E, Gorham D R. The Brief Psychiatric Rating Scale. Psychological Reports. Southern Universities Press 1962; 10: 799–812
- Larsson M, Forsman A. A high-performance liquid chromatography method for the assay of perphenazine and its dealkylated metabolite in serum after therapeutic doses. Ther Drug Monit 1983; 5: 225–8
- Simpson G M, Angus J WS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970; 45(suppl 212)11–2
- Bolvig Hansen L, Larsen N-E. Plasma levels of perphenazine related to clinical effects and extrapyramidal side effects. Clinical pharmacology in psychiatry, L F Gram, et al. Macmillan Press, London 1983; 175–81